BioArctic AB (publ) (BIOA-B) — Cash Flow Reinvestment Rate

Latest as of June 2025: 1.65x

BioArctic AB (publ) (BIOA-B) has a Cash Flow Reinvestment Rate of 1.65x as of June 2025, reinvesting Skr1.89 Billion (capex Skr1.15 Billion plus investments Skr-742.91 Million) from operating cash flow of Skr1.15 Billion. Check BIOA-B cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

1.65x
(Capex + Investments) / Operating CF

Total Reinvested

Skr1.89 Billion
Capex + Investments

Operating Cash Flow

Skr1.15 Billion
SEK

Capital Expenditures

Skr1.15 Billion
SEK

BioArctic AB (publ) Cash Flow Reinvestment Rate (2016–2023)

Historical reinvestment intensity for BioArctic AB (publ) across 3 annual periods. Explore BioArctic AB (publ) (BIOA-B) cash flow to debt to assess how comfortably operating cash covers total debt obligations.

Annual Cash Flow Reinvestment Rate for BioArctic AB (publ) (2016–2023)

Year-by-year capital reinvestment analysis for BioArctic AB (publ). For live market cap and broader valuation context, see BIOA-B market cap.

Year Reinvestment Rate Total Reinvested (SEK) Operating CF Capex YoY Change
2023 1.01x Skr314.00 Million Skr309.69 Million Skr7.44 Million ▲ +10035.0%
2019 0.01x Skr3.27 Million Skr327.17 Million Skr3.26 Million ▲ +13.7%
2016 0.01x Skr5.94 Million Skr675.13 Million Skr2.97 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow